A phase II randomized trial of observation versus stereotactic ablative radiation for oligometastatic prostate cancer (ORIOLE). Phillips, R., Radwan, N., Ross, A., Rowe, S. P., Gorin, M. A., Antonarakis, E. S., Deville, C., Greco, S. C., Denmeade, S. R., Paller, C., Song, D. Y., Diehn, M., Wang, H., Carducci, M., Pienta, K. J., Pomper, M. G., DeWeese, T. L., Dicker, A. P., Eisenberger, M. A., Tran, P. T. AMER SOC CLINICAL ONCOLOGY. 2017

View details for DOI 10.1200/JCO.2017.35.15_suppl.TPS5094

View details for Web of Science ID 000411931703082